ReviewAbdominal radiology (New York)2026
Predictive performance of CT-based artificial intelligence for predicting variceal bleeding in portal hypertension: a systematic review and meta-analysis.
Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectivesTo systematically evaluate the predictive accuracy of computed tomography (CT)-based artificial intelligence (AI) for predicting variceal bleeding (VB) in patients with portal hypertension, and to assess their potential utility as an opportunistic screening tool alongside Baveno VII criteria.
methodsWe searched PubMed, Embase, Web of Science, and Cochrane until December 16, 2025, for studies applying radiomics or machine learning algorithms to abdominal CT images for VB prediction. Quality was assessed using PROBAST + AI. A bivariate random-effects model was employed to calculate pooled sensitivity, specificity, and the area under the curve (AUC).
resultsTen studies encompassing 2,470 patients were included. CT-based AI models demonstrated promising predictive performance with a pooled sensitivity of 0.81 (95% Confidence Interval [CI]: 0.73-0.87), specificity of 0.85 (95% CI: 0.75-0.91), and an AUC of 0.88 (95% CI: 0.85-0.91). Unimodal image-only models achieved higher sensitivity than multimodal models (0.84 vs. 0.78). While a Vision Transformer architecture achieved the highest accuracy (AUC 0.98), it was limited to internal validation. Fagan's nomogram indicated a negative likelihood ratio of 0.23, reducing an assumed post-test probability of bleeding from 20% to 5%.
conclusionCT-based AI models exhibit high predictive efficacy and offer a promising non-invasive "gatekeeper" strategy for risk stratification. By leveraging routine imaging, these models may reduce unnecessary endoscopies for low-risk patients. However, given the reliance on internal validation and HBV-predominant cohorts, results should be interpreted as valuable adjunctive evidence rather than a standalone replacement. Large-scale, international multi-center validation is required to confirm generalizability before clinical implementation.
Indexed as
Identifiers
42159671What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.